Literature DB >> 15908381

Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires.

Rosângela Salerno-Gonçalves1, Rezwanul Wahid, Marcelo B Sztein.   

Abstract

CD8(+) T cells are likely to play an important role in host defense against Salmonella enterica serovar Typhi by several effector mechanisms, including lysis of infected cells (cytotoxicity) and gamma interferon (IFN-gamma) secretion. In an effort to better understand these responses, we studied the T-cell receptor (TCR) repertoire of serovar Typhi-specific CD8(+) T cells in humans. To this end, we determined the TCR beta chain (Vbeta) usage of CD8(+) T cells from three volunteers orally immunized with Ty21a typhoid vaccine by flow cytometry using a panel of monoclonal antibodies. Although TCR Vbeta usage varied among volunteers, we identified oligoclonal Vbeta subset expansions in individual volunteers (Vbeta 2, 5.1, 8, 17, and 22 in volunteer 1; Vbeta 1, 2, 5.1, 14, 17, and 22 in volunteer 2; and Vbeta 3, 8, 14, and 16 in volunteer 3). These subsets were antigen specific, as shown by cytotoxicity and IFN-gamma secretion assays on Vbeta sorted cells and on T-cell clones derived from these volunteers. Moreover, eight-color flow cytometric analysis showed that these clones exhibited a T effector memory phenotype (i.e., CCR7(-) CD27(-) CD45RO(+) CD62L(-)) and coexpressed gut homing molecules (e.g., high levels of integrin alpha4beta7, intermediate levels of CCR9, and low levels of CD103). In conclusion, our results show that long-term T-cell responses to serovar Typhi in Ty21a vaccinees are oligoclonal, involving multiple TCR Vbeta families. Moreover, these serovar Typhi-specific CD8(+) T cells bearing defined Vbeta specificities are phenotypically and functionally consistent with T effector memory cells with preferential gut homing potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908381      PMCID: PMC1111837          DOI: 10.1128/IAI.73.6.3521-3530.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Authors:  M M Levine; C Ferreccio; P Abrego; O S Martin; E Ortiz; S Cryz
Journal:  Vaccine       Date:  1999-10-01       Impact factor: 3.641

Review 3.  Regional specialization in the mucosal immune system: primed cells do not always home along the same track.

Authors:  P Brandtzaeg; I N Farstad; G Haraldsen
Journal:  Immunol Today       Date:  1999-06

Review 4.  The role of dendritic cells during Salmonella infection.

Authors:  Mary Jo Wick
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

5.  Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.

Authors:  C Bouneaud; P Kourilsky; P Bousso
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

6.  Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes.

Authors:  J W Huleatt; I Pilip; K Kerksiek; E G Pamer
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

7.  Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

Authors:  Marcela V Maus; Anna K Thomas; Debra G B Leonard; David Allman; Kathakali Addya; Katia Schlienger; James L Riley; Carl H June
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

8.  Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice.

Authors:  T N Bullock; D W Mullins; T A Colella; V H Engelhard
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

9.  T cell receptor Vbeta gene usage in Thai children with dengue virus infection.

Authors:  S J Gagnon; A Leporati; S Green; S Kalayanarooj; D W Vaughn; H A Stephens; S Suntayakorn; I Kurane; F A Ennis; A L Rothman
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

10.  Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.

Authors:  M F Pasetti; R J Anderson; F R Noriega; M M Levine; M B Sztein
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

View more
  39 in total

1.  Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

Authors:  Rezwanul Wahid; Rosangela Salerno-Gonçalves; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Journal:  Vaccine       Date:  2006-11-03       Impact factor: 3.641

Review 2.  Salmonella: from pathogenesis to therapeutics.

Authors:  Erin C Boyle; Jennifer L Bishop; Guntram A Grassl; B Brett Finlay
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

3.  Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.

Authors:  Rezwanul Wahid; Stephanie Fresnay; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2016-09-12       Impact factor: 3.969

Review 4.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

Review 6.  Commercializing diarrhea vaccines for travelers.

Authors:  Rosa López-Gigosos; Marina Segura-Moreno; Rosa Díez-Díaz; Elena Plaza; Alberto Mariscal
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

7.  Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.

Authors:  R Wahid; R Salerno-Gonçalves; C O Tacket; M M Levine; M B Sztein
Journal:  Mucosal Immunol       Date:  2008-07-02       Impact factor: 7.313

Review 8.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

9.  An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible α4β7high CD4+ T cells.

Authors:  Wei Zhu; Guoping Shi; Haijun Tang; Dorothy E Lewis; Xiao-Tong Song
Journal:  Curr HIV Res       Date:  2013-01       Impact factor: 1.581

10.  Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Authors:  Rezwanul Wahid; Shah J Zafar; Monica A McArthur; Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.